Print this page

Adults with Moderate-to-Severe Psoriasis


Study comparing two injectable treatments for moderate to severe plaque psoriasis

(SLU IRB #27193)

Dr. M. Yadira Hurley at Saint Louis University Dermatology is recruiting persons with moderate to severe plaque psoriasis.

The purpose of this research study is to evaluate and compare the safety and effectiveness of two FDA approved injectable medications for treatment of psoriasis.

You may be eligible if you:

  • Are 18 years of age or older in good general health
  • Have moderate to severe plaque psoriasis
  • Meet the physician evaluated and laboratory criteria for treatment
  • Agree to complete all study required visits and to prevent pregnancy for the length of the study

The study will last up to 56 weeks and will include multiple visits to the study site. Eligible participants if enrolled may receive the following:

  • Study Treatment
  • Laboratory testing
  • Research related exams
  • Compensation for time and travel

To learn more about this study contact:
Anastasia Kurta, DO
Dermatology Research Fellow
(314) 256-3439